Key result
Cardiopulmonary bypass is linked to ~9-fold higher arterial epinephrine by end of cross-clamping.
Why the study?
Cardiopulmonary bypass alters systemic hemodynamics and biochemical systems involved in cardiovascular regulation, motivating an investigation of changes in circulating epinephrine and norepinephrine levels in relation to events during bypass.
Does cardiopulmonary bypass alter circulating levels of epinephrine and norepinephrine across operative stages in surgical patients?
Observational (n=28)
Does cardiopulmonary bypass alter circulating levels of epinephrine and norepinephrine across operative stages in surgical patients?
Cardiopulmonary bypass induces a marked adrenomedullary release of epinephrine (ninefold increase) and a twofold increase in norepinephrine peaking at the end of aortic cross-clamping, which may compromise myocardial protection.
Answers are grounded in this paper and cite their sources.
Epinephrine surge during bypass may compromise myocardial protection; hypothesis-generating for adrenomedullary-targeted strategies in cardiac surgery.
Cardiopulmonary bypass (CPB) alters systemic hemodynamics and affects several biochemical systems involved in cardiovascular regulation. We investigated the changes in levels of circulating epinephrine (E) and norepinephrine (NE) and related them to events during CPB. Twenty-eight patients undergoing various surgical procedures were studied. Plasma E and NE were determined by radioenzymatic assay at eight stages of the operation. A ninefold increase in arterial E (from 75 +/- 13 to 708 +/- 117.3 pg/ml) occurred from prebypass (stage 1) measurements to the end of aortic cross-clamping (stage 4). The values at stage 4 were significantly higher (p less than 0.05) than at all other stages. E decreased rapidly, to 360 +/- 84.3 pg/ml, after myocardial and pulmonary reperfusion (stage 5). Arterial NE increased twofold from stage 1 to stage 4 (from 426 +/- 66.9 to 825 +/- 84.2, p less than 0.05). The increase in NE from initial CPB values (stage 2) to 30 minutes of aortic cross-clamping (stage 3) was associated with an increase in mean blood pressure (r = 0.51, p = 0.02). The peak increases in catecholamines occurred when the heart and lungs were excluded from the circulation, which suggests that either or both contributed to the increase. Because the increase in E was markedly greater than that in NE, the predominant humoral response to CPB appears to be adrenomedullary release of E. This significant increase in catecholamines could jeopardize myocardial protective measures during CPB.
No takes yet. Share an insight, caveat, or question.
Rêves et al. (1982) conducted an observational in Patients undergoing cardiopulmonary bypass during various surgical procedures (n=28). Cardiopulmonary bypass (end of aortic cross-clamping) vs. Prebypass baseline (stage 1) was evaluated on Circulating arterial epinephrine (E) and norepinephrine (NE) levels (pg/ml) (p=<0.05). Cardiopulmonary bypass increased arterial epinephrine ninefold and norepinephrine twofold by the end of aortic cross-clamping.
Synapse has enriched 10 related papers. Consider them for comparative context: